Tag:
comparative effectiveness
Latest Headlines
Latest Headlines
Experts jab over drug patent reform and the best approach to innovation
One of the most persistent arguments in the biopharma business these days is focused squarely on the length of patent protection a new treatment has when it goes on the market. The industry has
JAMA: Comparative heart study didn't change treatment
Four years ago, a highly publicized study found that cardiac stents didn't reduce the risk of heart attack or death any better than high-quality treatment with certain meds did. But even though drug
Comparative data absent for many new drugs
Only about half of new drugs approved in the last decade had comparative effectiveness data available at the time of their FDA approval, and approximately two-thirds of new drugs had this information
AZ plots push into comparative effectiveness
AstraZeneca is taking a gamble on more comparative-effectiveness research. The idea is to show that proving better than placebo isn't enough anymore. Payers are increasingly reluctant to accept
WellPoint jumps into comparative-effectiveness fray
More proof that the U.S. government isn't the only one interested in comparative effectiveness research: WellPoint, a major insurer, is already acting on its own comparisons. Based on a review of
Scots pit Rituxan against anti-TNF therapy
While the U.S. is just beginning to gear up for a comparative-effectiveness research push, a head-to-head trial of rheumatoid arthritis meds is launching in Scotland. Pitting an anti-TNF drug against
Comparative effectiveness money inspires hiring, dealmaking
The stimulus bill funding for comparative effectiveness research is already making its way onto the streets, backing new studies and spawning a series of related acquisitions, Bloomberg reports. For
Obama taps efficiency crusader to lead CMS
Get ready for another healthcare-reform tussle. As PhRMA gets set to lobby for changes to a Medicare-payment board created by the reform package, President Obama has nominated an efficiency advocate
Reform sets big budget for comparative research
The latest beneficiary of healthcare reform to step into the spotlight: Comparative effectiveness. The bill signed by President Obama earlier this week sets up a new institute for head-to-head
NEJM: Put comparative effectiveness on drug labels
While the government is busy backpedaling away from the idea that comparative effectiveness research should actually inform treatment decisions, some Stanford Med School researchers want to push
